These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
675 related articles for article (PubMed ID: 31577739)
1. Prediction of postoperative survival of triple-negative breast cancer based on nomogram model combined with expression of HIF-1α and c-myc. Cui J; Jiang H Medicine (Baltimore); 2019 Oct; 98(40):e17370. PubMed ID: 31577739 [TBL] [Abstract][Full Text] [Related]
2. A nomogram prediction for the survival of patients with triple negative breast cancer. Lin Y; Fu F; Lin S; Qiu W; Zhou W; Lv J; Wang C Oncotarget; 2018 Aug; 9(63):32108-32118. PubMed ID: 30181802 [TBL] [Abstract][Full Text] [Related]
3. The potential mechanism of HIF-1α and CD147 in the development of triple-negative breast cancer. Chen M; Liu Z; Zheng K; Hu C; Peng P Medicine (Baltimore); 2024 Jun; 103(23):e38434. PubMed ID: 38847725 [TBL] [Abstract][Full Text] [Related]
4. [Relationship between the expression of hypoxia-inducible factor-1alpha and epidermal growth factor receptor and micro vessel density and their clinical significance]. Lin P; Wang W; Cai WJ; Han CR; Sun Y; Li M; Sun BC Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2009 Jun; 44(6):480-5. PubMed ID: 19954019 [TBL] [Abstract][Full Text] [Related]
5. Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma. Bos R; van der Groep P; Greijer AE; Shvarts A; Meijer S; Pinedo HM; Semenza GL; van Diest PJ; van der Wall E Cancer; 2003 Mar; 97(6):1573-81. PubMed ID: 12627523 [TBL] [Abstract][Full Text] [Related]
6. Hypoxia-induced autophagy in triple negative breast cancer: association with prognostic variables, patients' survival and response to neoadjuvant chemotherapy. El-Guindy DM; Ibrahim FM; Ali DA; El-Horany HE; Sabry NM; Elkholy RA; Mansour W; Helal DS Virchows Arch; 2023 May; 482(5):823-837. PubMed ID: 36939902 [TBL] [Abstract][Full Text] [Related]
7. Oncogenic role of SIRT1 associated with tumor invasion, lymph node metastasis, and poor disease-free survival in triple negative breast cancer. Chung SY; Jung YY; Park IA; Kim H; Chung YR; Kim JY; Park SY; Im SA; Lee KH; Moon HG; Noh DY; Han W; Lee C; Kim TY; Ryu HS Clin Exp Metastasis; 2016 Feb; 33(2):179-85. PubMed ID: 26585892 [TBL] [Abstract][Full Text] [Related]
8. [Risk factor analysis on anastomotic leakage after laparoscopic surgery in rectal cancer patient with neoadjuvant therapy and establishment of a nomogram prediction model]. Jiang W; Feng MY; Dong XY; Dong SM; Zheng JX; Liu XM; Liu WJ; Yan J Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Aug; 22(8):748-754. PubMed ID: 31422613 [No Abstract] [Full Text] [Related]
9. Nomograms predict survival in elderly women with triple-negative breast cancer: A SEER population-based study. Feng R; Huang W; Liu B; Li D; Zhao J; Yu Y; Cao X; Wang X Technol Health Care; 2024; 32(4):2445-2461. PubMed ID: 38306071 [TBL] [Abstract][Full Text] [Related]
10. Hypoxia-inducible factor 1 alpha in high-risk breast cancer: an independent prognostic parameter? Gruber G; Greiner RH; Hlushchuk R; Aebersold DM; Altermatt HJ; Berclaz G; Djonov V Breast Cancer Res; 2004; 6(3):R191-8. PubMed ID: 15084243 [TBL] [Abstract][Full Text] [Related]
11. A prognostic model of triple-negative breast cancer based on miR-27b-3p and node status. Shen S; Sun Q; Liang Z; Cui X; Ren X; Chen H; Zhang X; Zhou Y PLoS One; 2014; 9(6):e100664. PubMed ID: 24945253 [TBL] [Abstract][Full Text] [Related]
12. Development and validation of nomograms predicting survival in Chinese patients with triple negative breast cancer. Yang Y; Wang Y; Deng H; Tan C; Li Q; He Z; Wei W; Zhou E; Liu Q; Liu J BMC Cancer; 2019 Jun; 19(1):541. PubMed ID: 31170946 [TBL] [Abstract][Full Text] [Related]
13. Clinicopathological and prognostic characteristics of triple- negative breast cancer (TNBC) in Chinese patients: a retrospective study. Li CY; Zhang S; Zhang XB; Wang P; Hou GF; Zhang J Asian Pac J Cancer Prev; 2013; 14(6):3779-84. PubMed ID: 23886182 [TBL] [Abstract][Full Text] [Related]
14. Clinical and pathological factors influencing survival in a large cohort of triple-negative breast cancer patients. Urru SAM; Gallus S; Bosetti C; Moi T; Medda R; Sollai E; Murgia A; Sanges F; Pira G; Manca A; Palmas D; Floris M; Asunis AM; Atzori F; Carru C; D'Incalci M; Ghiani M; Marras V; Onnis D; Santona MC; Sarobba G; Valle E; Canu L; Cossu S; Bulfone A; Rocca PC; De Miglio MR; Orrù S BMC Cancer; 2018 Jan; 18(1):56. PubMed ID: 29310602 [TBL] [Abstract][Full Text] [Related]
15. Radiomics features on ultrasound imaging for the prediction of disease-free survival in triple negative breast cancer: a multi-institutional study. Yu F; Hang J; Deng J; Yang B; Wang J; Ye X; Liu Y Br J Radiol; 2021 Oct; 94(1126):20210188. PubMed ID: 34478336 [TBL] [Abstract][Full Text] [Related]
16. [Expression of hypoxia-inducible factor 1α in gastric cancer and its clinical signficance]. Wu YL; Hu LN; Zheng CD; Sun RC; Zhang SX; Yan Q; Li YX Zhonghua Yi Xue Za Zhi; 2016 May; 96(18):1418-23. PubMed ID: 27266349 [TBL] [Abstract][Full Text] [Related]
17. Expression levels of PTEN, HIF-1α, and VEGF as prognostic factors in ovarian cancer. Shen W; Li HL; Liu L; Cheng JX Eur Rev Med Pharmacol Sci; 2017 Jun; 21(11):2596-2603. PubMed ID: 28678326 [TBL] [Abstract][Full Text] [Related]
18. The Milk Protein Alpha-Casein Suppresses Triple Negative Breast Cancer Stem Cell Activity Via STAT and HIF-1alpha Signalling Pathways in Breast Cancer Cells and Fibroblasts. Garner KEL; Hull NJ; Sims AH; Lamb R; Clarke RB J Mammary Gland Biol Neoplasia; 2019 Sep; 24(3):245-256. PubMed ID: 31529195 [TBL] [Abstract][Full Text] [Related]
19. Expression of C-myc and β-catenin and their correlation in triple negative breast cancer. Wang J; Li M; Chen D; Nie J; Xi Y; Yang X; Chen Y; Yang Z Minerva Med; 2017 Dec; 108(6):513-517. PubMed ID: 28889723 [TBL] [Abstract][Full Text] [Related]
20. Hypoxia inducible factor-1alpha correlates with VEGF-C expression and lymphangiogenesis in breast cancer. Schoppmann SF; Fenzl A; Schindl M; Bachleitner-Hofmann T; Nagy K; Gnant M; Horvat R; Jakesz R; Birner P Breast Cancer Res Treat; 2006 Sep; 99(2):135-41. PubMed ID: 16555123 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]